Lead Product(s): ATYR2810
Therapeutic Area: Oncology Product Name: ATYR2810
Highest Development Status: IND Enabling Product Type: Large molecule
Partner/Sponsor/Collaborator: aTyr Pharma
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership April 14, 2021
Under the terms of the agreement, Lonza will utilize its Ibex® Design, a fully integrated end-to-end program, to manufacture cGMP material for ATYR2810.